Evidence map›Paper›PMID 42484331›Full record

ArticleJournal of virology2026

Structural determination of the HIV-1 Variable Region 3 epitope of antibody 19b.

Susan K Fetics, Ariha Mehta, Nathan I Nicely, Chun-Hsing Josh Chen, Jared Lindenberger, Priyamvada Acharya

Abstract read
In one paragraph

Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Susan K FeticsDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Ariha MehtaDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Nathan I NicelyUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Chun-Hsing Josh ChenUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Jared LindenbergerDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
Priyamvada AcharyaDuke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.ORCID 0000-0002-0089-277X

Funding

Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block reboundU54AI170752 · NIAID · DUKE UNIVERSITY · PI Rory Henderson · 2022 to 2026
$32.0M
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodiesU01AI169587 · NIAID · UNIVERSITY OF MINNESOTA · PI Priyamvada Acharya, Brandon James DeKosky · 2022 to 2026
$7.8M
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics developmentR01AI145687 · NIAID · DUKE UNIVERSITY · PI Priyamvada Acharya · 2019 to 2026
$6.9M
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1R01AI165147 · NIAID · DUKE UNIVERSITY · PI ACHARYA, PRIYAMVADA, WILLIAMS, WILTON B · 2021 to 2025
$3.4M
NIAID NIH HHS R01 AI145687NIAID NIH HHS R01 AI165147NIAID NIH HHS U01 AI169587NIAID NIH HHS U54 AI170752NIH HHS R01 AI145687NIH HHS R01 AI165147NIH HHS U01 AI169587NIH HHS U54 AI170752
6 · The paper itself

Abstract

The HIV-1 Envelope (Env) in its pre-receptor "closed" conformation is targeted by broadly neutralizing antibodies (bnAbs), while its receptor-bound "open" conformation exposes immunodominant epitopes targeted by non-neutralizing antibodies. A human immunoglobulin G (IgG) monoclonal antibody (mAb), 19b, binds an Env third variable (V3) loop epitope that is only exposed in the open Env conformation. Despite widespread use of 19b to detect the open Env conformation in immunoassays, its epitope has not yet been structurally defined. Here, we determine crystal structures of ligand-free and V3 peptide-bound 19b Fab to visualize details of this interaction. 19b utilizes both its heavy and light chains to interact with the V3 loop. The 5-residue heavy-chain complementarity-determining region (CDR H3) forms a hydrophobic binding pocket to bind V3 residues. 19b adopts a cradle-binding mode, with its CDRH1, CDRL2, and CDRL3 mediating interactions with the V3 regions flanking the conserved GPGR/Q motif, while making only limited contacts with the GPGR arch region. Our high-resolution structures elucidate the epitope, binding mode, and the structural basis for the broad reactivity of 19b, thereby filling a gap in our knowledge of a widely used reagent in immunoassays. IMPORTANCE: Here, we determine high-resolution crystal structures of 19b, an antibody that binds the receptor-bound "open" conformation of the HIV-1 envelope (Env) protein at an epitope located within its third variable (V3) loop. Despite widespread use of 19b to detect the open Env conformation in immunoassays, its epitope has not yet been structurally defined. Our high-resolution structures, by elucidating the epitope, binding mode and the structural basis for the broad reactivity of 19b, fill a gap in our knowledge of a reagent that is widely used in immunoassays.

Indexed as

Antibodies, MonoclonalEpitopesHIV-1HIV AntibodiesHIV Envelope Protein gp120Antibodies, NeutralizingCrystallography, X-RayHumansImmunoglobulin Fab FragmentsModels, MolecularProtein BindingProtein ConformationAntibodies, MonoclonalAntibodies, NeutralizingEpitopesHIV AntibodiesHIV Envelope Protein gp120Immunoglobulin Fab Fragmentscradle binding modecrystal structureHIV-1 envelopemonoclonal antibody 19bnon-neutralizingV3 epitope

Identifiers

PMID42484331
PMCPMC13483476

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.